Clinical Trial

Bacteria in Dental Plaque and Atheroma Plaque

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 3, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Periodontitis is considered a focus of infection where oral bacteria, bacterial by-products or inflammatory mediators can interact with other parts of the organism via the blood. Periodontal pathogen components such as DNA, RNA or specific antigens of P. gingivalis, Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), Treponema denticola (T. denticola), Fusobacterium nucleatum (F. nucleatum) or Campylobacter rectus have been isolated from different tissues such as atheroma plaques, placenta, amniotic sac and respiratory tract. It has been reported that periodontitis may contribute to endothelial dysfunction leading to the formation of atherosclerosis.
Trial Details
NCT Number NCT07100574
Lead Sponsor Istanbul Saglik Bilimleri University
Conditions Gingival Inflammation, Dental Plaque, Atheroma Plaque, Oral Bacteria
Enrollment 60 participants
Start Date 2024-12-10
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-03